✦ LIBER ✦

Immunotherapy for Pediatric Central Nervous System Tumors

✍ Scribed by Sharon L. Gardner; Nabil Ahmed; Hideho Okada

Book ID: 116281217
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 198 KB
Volume: 16
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2009.11.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tumors of the pediatric central nervous

Tumors of the pediatric central nervous system

✍ Michael E Cohen 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 19 KB

Molecular genetics of pediatric central

Molecular genetics of pediatric central nervous system tumors

✍ Nicole J. Ullrich; Scott L. Pomeroy 📂 Article 📅 2006 🏛 Current Science Inc. 🌐 English ⚖ 208 KB

Cytogenetic analysis of 39 pediatric cen

Cytogenetic analysis of 39 pediatric central nervous system tumors

✍ Pamela S. Karnes; Tuan N. Tran; Mei Ying Cui; Corey Raffel; Floyd H. Gilles; Joh 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 546 KB

Cytogenetic analysis of 109 pediatric ce

Cytogenetic analysis of 109 pediatric central nervous system tumors

✍ Etela Neumann; Dagmar K. Kalousek; Margaret G. Norman; Paul Steinbok; D.Douglas 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 772 KB

Phase II evaluation of topotecan for ped

Phase II evaluation of topotecan for pediatric central nervous system tumors

✍ Susan M. Blaney; Peter C. Phillips; Roger J. Packer; Richard L. Heideman; Stacey 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 473 KB 👁 2 views

## BACKGROUND. Topotecan is a topoisomerase I inhibitor that has good penetration across the blood-brain barrier and significant antitumor activity against human brain tumor xenografts. In a Phase I trial in children with refractory cancer, topotecan was well tolerated when administered as a 24-ho

Central nervous system tumors

✍ Lynn S. Ashby; Matthew M. Troester; William R. Shapiro 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 452 KB